ursodeoxycholic acid UDCA
Selected indexed studies
- Advances in Pharmacological Activities, Biosynthesis, and Structural Modification of Ursodeoxycholic Acid (UDCA): A Review. (Drug Des Devel Ther, 2025) [PMID:41376668]
- Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. (Clin Liver Dis, 2004) [PMID:15062194]
- Ursodeoxycholic Acid (UDCA) Reduces Hepatocyte Apoptosis by Inhibiting Farnesoid X Receptor (FXR) in Hemorrhagic Shock (HS). (Curr Mol Med, 2023) [PMID:35619282]
_Worker-drafted node — pending editorial review._
Connections
ursodeoxycholic acid UDCA helps
Sources
- Advances in Pharmacological Activities, Biosynthesis, and Structural Modification of Ursodeoxycholic Acid (UDCA): A Review. (2025) pubmed
- Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. (2004) pubmed
- Ursodeoxycholic Acid (UDCA) Reduces Hepatocyte Apoptosis by Inhibiting Farnesoid X Receptor (FXR) in Hemorrhagic Shock (HS). (2023) pubmed
- Gut symbiont-derived ursodeoxycholic acid promotes fatty acid oxidation to protect against renal ischemia-reperfusion injury. (2025) pubmed
- Mitochondria-targeted nanovesicles for ursodeoxycholic acid delivery to combat neurodegeneration by ameliorating mitochondrial dysfunction. (2025) pubmed
- Therapeutic role of ursodeoxycholic acid in colitis-associated cancer via gut microbiota modulation. (2023) pubmed
- Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride. (2021) pubmed
- The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases. (2025) pubmed
- Gut microbiota-mediated ursodeoxycholic acids regulate the inflammation of microglia through TGR5 signaling after MCAO. (2024) pubmed
- Ursodeoxycholic acid in pregnancy? (2019) pubmed